Randomized study of the effect of gadopiclenol, a new gadolinium‐based contrast agent, on the QTc interval in healthy subjects-Reference-Cited by-同舟云学术

Randomized study of the effect of gadopiclenol, a new gadolinium‐based contrast agent, on the QTc interval in healthy subjects

Published:2020-04-27 Issue:11 Volume:86 Page:2174-2181
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Funck‐Brentano Christian¹^ORCID,Felices Mathieu²,Le Fur Nathalie³^ORCID,Dubourdieu Corinne³,Desché Pierre³^ORCID,Vanhoutte Frédéric⁴,Voiriot Pascal⁵

Affiliation:

1. INSERM, CIC‐1901 and UMRS 1166, Paris, France; AP‐HP, Pitié‐Salpêtrière Hospital, Department of Pharmacology and CIC‐1901, Paris, France; Sorbonne Université Médecine, Paris, France; Institute of Cardiometabolism and Nutrition (ICAN) Paris France

2. Phinc Massy France

3. Guerbet Roissy CDG Cedex France

4. SGS Clinical Pharmacology Unit, ZNA Stuivenberg Antwerp Belgium

5. Cardiabase Nancy France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14309

Reference27 articles.

1. Use of contrast agents in oncological imaging: magnetic resonance imaging